Published by Iain Gilbert on 24th October 2025
(Sharecast News) - Drugmaker GSK said on Friday that the US Food and Drug Administration had approved its Blenrep asset in combination with bortezomib and dexamethasone for the treatment of adults with relapsed or refractory multiple myeloma.
URL: http://www.digitallook.com/dl/news/story/35446148/...